TD Cowen Updates Financial Model Citing Upcoming Q4 Results for Lantheus Holdings, Inc. (LNTH)
TheFly reported on January 29 that TD Cowen lowered its price target on LNTH to $75 from $80 and gave it a Buy rating.
Lantheus Holdings Inc. (LNTH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 5,427,479 | $361,198,727 | +57% | 1.7% |
| 2. | Point72 Asset Management Steve Cohen | 1,014,369 | $67,506,257 | 0.08% | |
| 3. | Deerfield Management James E. Flynn | 827,999 | $55,103,333 | 0.7% | |
| 4. | Citadel Investment Group Ken Griffin | 644,196 | $42,871,243 | +25% | 0.01% |
| 5. | 37,211,000 | $42,549,960 | +96% | 12.85% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.60 | 1,000 | $18,600.00 | 16,211 | 2021-03-05 | Filing | |
| $18.02 | 1,000 | $18,020.00 | 15,211 | 2021-02-26 | Filing | |
| $19.39 | 1,000 | $19,390.00 | 14,211 | 2021-02-19 | Filing | |
| $20.03 | 1,000 | $20,030.00 | 13,211 | 2021-02-12 | Filing | |
| $17.94 | 1,000 | $17,940.00 | 12,211 | 2021-02-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.15 | 3,365,000 | $188,944,750.00 | 3,477,227 | 2025-08-20 | Filing | |
| $55.34 | 41,000 | $2,268,940.00 | 6,842,227 | 2025-08-19 | Filing | |
| $56.15 | 3,365,000 | $188,944,750.00 | 3,477,227 | 2025-08-20 | Filing | |
| $55.34 | 41,000 | $2,268,940.00 | 6,842,227 | 2025-08-19 | Filing | |
| $53.57 | 3,060 | $163,924.20 | 108,214 | 2025-08-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,266,414 | $550,129,840 | 0.01% | |
| 2. | 6,699,381 | $445,843,806 | 0.01% | |
| 3. | 5,707,247 | $379,821,075 | 0.17% | |
| 4. | AmundiBOND | 2,600,000 | $297,570,000 | 0.08% |
| 5. | 4,323,526 | $287,730,636 | 0.01% |
News See All
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
According to research, the U.S.
Truist Sees Upside in Lantheus Holdings, Inc. (LNTH) Despite PYLARIFY Pressure
On December 11, TheFly reported that Truist Securities upgraded LNTH from Hold to Buy and raised its price target to $80, reflecting a more optimistic view of the company’s growth prospects and belief...
9 Most Undervalued Pharma Stocks to Buy Right Now
The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.
Wall Street Remains Bullish On Lantheus Holdings, Inc. (LNTH)
Lantheus Holdings, Inc. (NASDAQ:LNTH) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Lantheus Holdings, Inc.
12 Cheap Healthcare Stocks to Buy Heading into 2026
Since the pandemic, healthcare is one of the sectors that have remained in the spotlight even amid market twists.
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q3 2025 Earnings Call Transcript
Operator: Good morning. Welcome to Lantheus' Third Quarter 2025 Conference Call.
Here’s Why Lantheus Holdings (LNTH) Fell in Q3
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Goldman Sachs Downgrades Lantheus (LNTH) PT to $77 Amid PYLARIFY Pricing Pressure, Slow Alzheimer's Drug Uptake
Lantheus Holdings Inc. (NASDAQ:LNTH) is one of the best value stocks to invest in now. On October 8, Goldman Sachs downgraded Lantheus to Neutral from Buy with a price target of $77, down from $110.
10 Best Value Stocks to Invest in Now
On October 7, Lori Calvasina, RBC Capital Markets head of US equity strategy, joined CNBC's 'Power Lunch' to discuss Calvasina's thoughts on current valuations.
Hedge Fund Resource Center